John C Rasmussen1, Banghe Zhu2, John R Morrow2, Melissa B Aldrich2, Aaron Sahihi2, Stuart A Harlin3, Caroline E Fife4, Thomas F O'Donnell5, Eva M Sevick-Muraca2. 1. Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Tex. Electronic address: John.Rasmussen@uth.tmc.edu. 2. Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Tex. 3. Department of Cardiothoracic Vascular Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Tex. 4. The Wound Care Clinic, CHI St. Luke's Health, The Woodlands Hospital, The Woodlands, Tex; Department of Geriatrics, Baylor College of Medicine, Houston, Tex. 5. Division of Vascular Surgery, Tufts Medical Center, Boston, Mass.
Abstract
OBJECTIVE: We used near-infrared fluorescence lymphatic imaging in a pilot study to assess the lymphatics in preulcerative (C2-C4) venous insufficiency and determine whether involvement and/or degradation of lymphatic anatomy or function could play a role in the progression of chronic venous insufficiency. We also explored the role of lymphatics in early peripheral arterial disease. METHODS: After informed consent and intradermal injections of indocyanine green for rapid lymphatic uptake, near-infrared fluorescence lymphatic imaging was used to assess the lymphatic anatomic structure and quantify the lymphatic propulsion rates in subjects with early venous insufficiency. The anatomic observations included interstitial backflow, characterized by the abnormal spreading of indocyanine green from the injection site primarily into the surrounding interstitial tissues; dermal backflow, characterized by the retrograde movement of dye-laden lymph from collecting lymphatics into the lymphatic capillaries; and lymphatic vessel segmentation and dilation. RESULTS: Ten subjects with venous insufficiency were enrolled, resulting in two legs with C2 disease, nine legs with C3 disease, eight legs with C4 disease, and one leg with C5 disease. Interstitial and/or dermal backflow were observed in 25%, 33%, and 41% of the injection sites in each limb with C2, C3, and C4 disease, respectively. Distinct vessel segmentation and dilation were observed in limbs with a C3 and higher classification, and dermal backflow proximal to the injection sites was observed in two legs with C4 disease and in the inguinal region of the C5 study subject. The overall average lymph propulsion rates were 1.3 ± 0.4, 1.2 ± 0.7, and 0.8 ± 0.5 contractile events/min for limbs with C2, C3, and C4 disease, respectively. One subject with peripheral arterial disease, who had previously undergone bypass surgery, presented with extensive dermal backflow and lymphatic reflux. CONCLUSIONS: Near-infrared fluorescence lymphatic imaging demonstrated that, compared with normal health subjects, the lymphatic anatomy and contractile function generally degrade with the severity of venous insufficiency. Lymphatic abnormalities mimic those in early cancer-acquired lymphedema subjects, as previously observed by us and others. Additional studies are needed to decipher the relationship, including any causality, between lymphatic dysfunction and peripheral vascular disease and venous insufficiency.
OBJECTIVE: We used near-infrared fluorescence lymphatic imaging in a pilot study to assess the lymphatics in preulcerative (C2-C4) venous insufficiency and determine whether involvement and/or degradation of lymphatic anatomy or function could play a role in the progression of chronic venous insufficiency. We also explored the role of lymphatics in early peripheral arterial disease. METHODS: After informed consent and intradermal injections of indocyanine green for rapid lymphatic uptake, near-infrared fluorescence lymphatic imaging was used to assess the lymphatic anatomic structure and quantify the lymphatic propulsion rates in subjects with early venous insufficiency. The anatomic observations included interstitial backflow, characterized by the abnormal spreading of indocyanine green from the injection site primarily into the surrounding interstitial tissues; dermal backflow, characterized by the retrograde movement of dye-laden lymph from collecting lymphatics into the lymphatic capillaries; and lymphatic vessel segmentation and dilation. RESULTS: Ten subjects with venous insufficiency were enrolled, resulting in two legs with C2 disease, nine legs with C3 disease, eight legs with C4 disease, and one leg with C5 disease. Interstitial and/or dermal backflow were observed in 25%, 33%, and 41% of the injection sites in each limb with C2, C3, and C4 disease, respectively. Distinct vessel segmentation and dilation were observed in limbs with a C3 and higher classification, and dermal backflow proximal to the injection sites was observed in two legs with C4 disease and in the inguinal region of the C5 study subject. The overall average lymph propulsion rates were 1.3 ± 0.4, 1.2 ± 0.7, and 0.8 ± 0.5 contractile events/min for limbs with C2, C3, and C4 disease, respectively. One subject with peripheral arterial disease, who had previously undergone bypass surgery, presented with extensive dermal backflow and lymphatic reflux. CONCLUSIONS: Near-infrared fluorescence lymphatic imaging demonstrated that, compared with normal health subjects, the lymphatic anatomy and contractile function generally degrade with the severity of venous insufficiency. Lymphatic abnormalities mimic those in early cancer-acquired lymphedema subjects, as previously observed by us and others. Additional studies are needed to decipher the relationship, including any causality, between lymphatic dysfunction and peripheral vascular disease and venous insufficiency.
Authors: Patricia E Burrows; Manuel L Gonzalez-Garay; John C Rasmussen; Melissa B Aldrich; Renie Guilliod; Erik A Maus; Caroline E Fife; Sunkuk Kwon; Philip E Lapinski; Philip D King; Eva M Sevick-Muraca Journal: Proc Natl Acad Sci U S A Date: 2013-05-06 Impact factor: 11.205
Authors: Eva M Sevick-Muraca; Ruchi Sharma; John C Rasmussen; Milton V Marshall; Juliet A Wendt; Hoang Q Pham; Elizabeth Bonefas; Jessica P Houston; Lakshmi Sampath; Kristen E Adams; Darlene Kay Blanchard; Ronald E Fisher; Stephen B Chiang; Richard Elledge; Michel E Mawad Journal: Radiology Date: 2008-01-25 Impact factor: 11.105
Authors: John C Rasmussen; Sunkuk Kwon; Amanda Pinal; Alexander Bareis; Fred C Velasquez; Christopher F Janssen; John R Morrow; Caroline E Fife; Ron J Karni; Eva M Sevick-Muraca Journal: Physiol Rep Date: 2020-02
Authors: Paula M C Donahue; Rachelle Crescenzi; Kalen J Petersen; Maria Garza; Niral Patel; Chelsea Lee; Sheau-Chiann Chen; Manus J Donahue Journal: Lymphat Res Biol Date: 2021-11-08 Impact factor: 2.349
Authors: P S Russell; R Velivolu; V E Maldonado Zimbrón; J Hong; I Kavianinia; A J R Hickey; J A Windsor; A R J Phillips Journal: Front Pharmacol Date: 2022-07-22 Impact factor: 5.988
Authors: John C Rasmussen; Melissa B Aldrich; Caroline E Fife; Karen L Herbst; Eva M Sevick-Muraca Journal: Obesity (Silver Spring) Date: 2022-06-15 Impact factor: 9.298